| |
| | |
| | |  |
BioReliance Launches Next-Generation Genotoxicity Screening Service
BioReliance has contracted with Gentronix to offer their GreenScreen HC in vitro assay as a major part of BioReliance's portfolio of genotoxicity screening services. GreenScreen HC, in conjunction with Ames II assays, allows pharmaceutical companies to test for genotoxic potential earlier in the preclinical development process, using only a few milligrams of test compound as opposed to the gram quantities required by current ICH regulatory tests. Click here to read the press release.
Bioreliance Launches iNet, a Web-Based Tool for tracking Electronic Submissions of Biologics Tests
BioReliance is pleased to announce the release of iNet, a proprietary information technology system for submitting and tracking test article details via a controlled and secure Internet access from any location worldwide. Now you can view the status of current and past studies, keep informed of when testing will be completed, download reports, and allow your colleagues to view the status of your tests. iNet is currently available to US biologics testing customers upon request, but will be made available to a larger audience soon. Click here to read the press release.
|
|
|
|
|
At BioReliance, our highly
experienced Virology group offers comprehensive tests for the detection
of human and animal viral contaminants, thereby helping ensure the safety
of your biological product.
|
Our expertise allows us to provide you with all your
virological and cell-based testing requirements: from regulatory and testing
advice, to supply expertise in assay transfer and assay development for
all stages of the drug development process, from early proof of concept
experiments to analysis of final product material. Our GLP/cGMP facilities
all operate to meet appropriate European, Japanese and US regulatory requirements.
|  |
|
|
